Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2020
Data Digitizing: Accurate and Precise Data Extraction for Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic ModelingJan-Georg Wojtyniak, Hannah Britz, Dominik Selzer, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 10, 2018
PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and DigoxinNina Hanke, Sebastian Frechen, Daniel Moj, et al.
Cancer Chemotherapy and Pharmacology|October 9, 2017
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specificationDaniel Moj, Hannah Britz, Jürgen Burhenne, et al.
Clinical Pharmacokinetics|March 14, 2020
Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy StrategiesLukas Kovar, Dominik Selzer, Hannah Britz, et al.
The AAPS Journal|November 9, 2016
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication RegimensDaniel Moj, Nina Hanke, Hannah Britz, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2019
Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and MidazolamHannah Britz, Nina Hanke, Anke-Katrin Volz, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2017
A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysisNina Hanke, Michael Teifel, Daniel Moj, et al.
Pharmaceutical Research|November 25, 2020
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug InteractionsHannah Britz, Nina Hanke, Mitchell E Taub, et al.
Pageof 1